Cognition Therapeutics Inc (CGTX): Capital Expenditures

Annual figures by period end, from SEC filings.

$4.0K
Year ended 2024-12-31
-47.1%
3-year compound annual growth
$171.0K2020-12-31: $10.0K2021-12-31: $27.0K2022-12-31: $171.0K2023-12-31: $147.0K2024-12-31: $4.0K$4.0K
2020-12-31 Capital Expenditures (USD) 2024-12-31
Period endedCapital ExpendituresChange YoYSource filing
2024-12-31$4.0K-97.3%2026-03-26, From 2024-01-01
2023-12-31$147.0K-14.0%2025-03-20, From 2023-01-01
2022-12-31$171.0K+533.3%2024-03-26, From 2022-01-01
2021-12-31$27.0K+170.0%2023-03-23, From 2021-01-01
2020-12-31$10.0Kn/a2022-03-30, From 2020-01-01